Company · CIK 1785345
Landos Biopharma, Inc.
| CIK | 1785345 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | VA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-263836 | 2022-03-24 | 2024-05-23 | 3 | |
| 333-252083 | 2021-01-13 | 2021-02-04 | 5 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-05-23 | RWWithdrawn | 333-263836 | 0001193125-24-146069 |
| 2022-08-15 | EFFECTDeclared effective | 333-263836 | 9999999995-22-002380 |
| 2022-03-24 | S-3Shelf registered | 333-263836 | 0001193125-22-084033 |
| 2021-02-04 | 424B4Final prospectus | 333-252083 | 0001193125-21-028952 |
| 2021-02-03 | EFFECTDeclared effective | 333-252083 | 9999999995-21-000415 |
| 2021-02-01 | S-1/AAmendment | 333-252083 | 0001193125-21-024746 |
| 2021-01-28 | S-1/AAmendment | 333-252083 | 0001193125-21-020102 |
| 2021-01-13 | S-1Registration filed | 333-252083 | 0001193125-21-008210 |
| 2020-07-24 | DRSDraft made public | 377-03328 | 0000950123-20-007158 |